Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 289

1.

Three independent yearly analyses of the spectrum and potency of metronidazole: a multicenter study of 1,108 contemporary anaerobic clinical isolates.

Erwin ME, Fix AM, Jones RN.

Diagn Microbiol Infect Dis. 2001 Feb;39(2):129-32.

PMID:
11248527
[PubMed - indexed for MEDLINE]
2.

Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria.

Citron DM, Appleman MD.

Antimicrob Agents Chemother. 2001 Jan;45(1):345-8.

PMID:
11120995
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.

Roberts SA, Shore KP, Paviour SD, Holland D, Morris AJ.

J Antimicrob Chemother. 2006 May;57(5):992-8. Epub 2006 Feb 28.

PMID:
16507560
[PubMed - indexed for MEDLINE]
Free Article
4.

In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.

Shafran SD, Wong J, Chow AW.

Antimicrob Agents Chemother. 1985 May;27(5):749-52.

PMID:
4015069
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Susceptibility of anaerobic bacteria in Auckland: 1991-1996.

Shore KP, Pottumarthy S, Morris AJ.

N Z Med J. 1999 Nov 12;112(1099):424-6.

PMID:
10678225
[PubMed - indexed for MEDLINE]
6.

Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.

Papaparaskevas J, Pantazatou A, Katsandri A, Legakis NJ, Avlamis A; Hellenic Study Group for Gram-Negative Anaerobic Bacteria.

Clin Microbiol Infect. 2005 Oct;11(10):820-4.

PMID:
16153256
[PubMed - indexed for MEDLINE]
7.

Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods.

Ednie LM, Credito KL, Khantipong M, Jacobs MR, Appelbaum PC.

J Antimicrob Chemother. 2000 May;45(5):633-8.

PMID:
10797085
[PubMed - indexed for MEDLINE]
Free Article
8.

[Study of obligate anaerobic bacterial sensitivity to tinidazole and metronidazole (determination of minimal inhibiting concentration--MIC)].

Kałowski M, Dybicki J, Kedzia A, Lukiański M.

Wiad Lek. 1993 Mar;46(5-6):211-5. Polish.

PMID:
8249400
[PubMed - indexed for MEDLINE]
9.

["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].

Litterio M, Bianchini H, Carloni G, Di Martino A, Fernández Canigia L, Greco G, Legaria C, Rollet R, Rossetti A, Predari SC, Castello L.

Rev Argent Microbiol. 2004 Jul-Sep;36(3):130-5. Spanish.

PMID:
15559195
[PubMed - indexed for MEDLINE]
10.

Activity of cefotetan against anaerobic bacteria.

Dias MB, Jacobus NV, Tally FP, Gorbach SL.

Diagn Microbiol Infect Dis. 1986 Apr;4(4):359-63.

PMID:
3457672
[PubMed - indexed for MEDLINE]
11.

Activity of cefmetazole against anaerobic bacteria.

Cornick NA, Jacobus NV, Gorbach SL.

Antimicrob Agents Chemother. 1987 Dec;31(12):2010-2.

PMID:
3481541
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria.

Ackermann G, Schaumann R, Pless B, Claros MC, Goldstein EJ, Rodloff AC.

Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):228-32.

PMID:
10795599
[PubMed - indexed for MEDLINE]
13.

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.

Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Golan Y, Goldstein EJ, Finegold SM, Harrell LJ, Hecht DW, Jenkins SG, Pierson C, Venezia R, Yu V, Rihs J, Gorbach SL.

Antimicrob Agents Chemother. 2007 May;51(5):1649-55. Epub 2007 Feb 5.

PMID:
17283189
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Antibacterial activity of meropenem and selected comparative agents against anaerobic bacteria at seven North American centers.

Sheikh W, Pitkin DH, Nadler H.

Clin Infect Dis. 1993 Jun;16 Suppl 4:S361-6.

PMID:
8324148
[PubMed - indexed for MEDLINE]
15.

Susceptibility of anaerobic bacteria isolated from intra-abdominal infections to ofloxacin and interaction of ofloxacin with metronidazole.

Goldstein EJ, Citron DM.

Antimicrob Agents Chemother. 1991 Nov;35(11):2447-9.

PMID:
1804024
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.

Goldstein EJ, Citron DM.

Antimicrob Agents Chemother. 1985 Feb;27(2):162-6.

PMID:
3985600
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].

Dubreuil L, Devos J, Beerens H, Romond C.

Pathol Biol (Paris). 1988 May;36(5):488-92. French.

PMID:
3043345
[PubMed - indexed for MEDLINE]
18.

A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms.

Leone F, Morandotti MG, Mazzella P, Sanna A, Ravizzola G, Colombrita D, Pinzi G, Turano R, Menozzi MG, Lecchini R, et al.

J Int Med Res. 1990 May-Jun;18(3):191-200.

PMID:
2193834
[PubMed - indexed for MEDLINE]
19.

Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.

Edmiston CE Jr, Krepel CJ, Kehl KS, Seabrook GR, Somberg LB, Almassi GH, Smith TL, Loehrl TA, Brown KR, Lewis BD, Towne JB.

J Antimicrob Chemother. 2005 Nov;56(5):872-8. Epub 2005 Sep 26.

PMID:
16186167
[PubMed - indexed for MEDLINE]
Free Article
20.

Comparative in-vitro activity of Sch 34343 for a wide spectrum of clinically significant anaerobic bacteria.

Wells CL, Wilkins TD.

J Antimicrob Chemother. 1985 Jun;15 Suppl C:177-82.

PMID:
4030546
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk